Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand patents under the Hatch-Waxman Act. This system has saved U.S. consumers over $1.2 trillion since 1990 by speeding up access to cheaper medicines.